| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/03/1997 | WO1996037621A3 Multimeric proteins |
| 01/03/1997 | WO1996037201A3 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/03/1997 | CA2224649A1 Melatonin agonists for treating benign prostatic hyperplasia |
| 01/03/1997 | CA2224555A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 01/03/1997 | CA2224440A1 New vitamin d derivatives with substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 01/03/1997 | CA2223792A1 Urocortin peptides |
| 01/03/1997 | CA2221027A1 Novel use for pyrrole derivatives |
| 01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
| 01/02/1997 | EP0751217A2 Enhancing keratinocyte migration with clostridiopeptidase-A-collagenase |
| 01/02/1997 | EP0750668A1 NOVEL MUTEINS OF IFN-$g(b) |
| 01/02/1997 | EP0750664A1 Reproduction and utilization of functional human tissue |
| 01/02/1997 | EP0750637A1 Dna encoding cai resistance proteins and uses thereof |
| 01/02/1997 | EP0750631A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
| 01/02/1997 | EP0750614A1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 01/02/1997 | EP0750608A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/02/1997 | EP0750502A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies |
| 01/02/1997 | EP0564461B1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 01/01/1997 | CN1139435A New ginkgolide derivatives and process for preparing them |
| 01/01/1997 | CN1139430A Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139427A Malarial aspartic protease inhibitors |
| 01/01/1997 | CN1139383A Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139111A Novel pyridine compounds, processes for their preparation and pharmaceutical compositions which contain them |
| 01/01/1997 | CN1139110A Inhibitng photodecomposition of 3-substituted-2-oxindoles |
| 12/31/1996 | US5589501 Pharmaceutical compounds |
| 12/31/1996 | US5589496 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor agonist activity |
| 12/31/1996 | US5589482 Benzo-thiophene estrogen agonists to treat prostatic hyperplasia |
| 12/31/1996 | US5589475 Benzodiazepine treatment |
| 12/31/1996 | US5589471 Vitamin D analogues containing a hydroxy or alkylated hydroxy group in the 20-position |
| 12/31/1996 | US5589465 Glycolipid derivatives acting as ligands for selectins |
| 12/31/1996 | US5589458 Compounds that inhibit T cell proliferation and methods for using the same |
| 12/31/1996 | US5589452 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 12/31/1996 | US5589375 Dephosphorylation |
| 12/31/1996 | US5589178 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof |
| 12/31/1996 | US5589156 Prilocaine and hydrofluourocarbon aerosol preparations |
| 12/31/1996 | US5589047 Using dielectrophoresis for genetic engineering |
| 12/27/1996 | WO1996041887A1 Dnase-active protein |
| 12/27/1996 | WO1996041869A1 Cis-9,10-octadecenoamidase |
| 12/27/1996 | WO1996041807A1 Rapamycin derivatives |
| 12/27/1996 | WO1996041795A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041640A1 Bradykinin analogs as selective thrombin inhibitors |
| 12/27/1996 | WO1996041630A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | WO1996041624A1 TNF-α CONVERTING ENZYME |
| 12/27/1996 | WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 12/27/1996 | WO1996041618A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 12/27/1996 | WO1996041616A1 Formulations and methods for providing prolonged local anesthesia |
| 12/27/1996 | WO1996041523A1 Fgf9 as a specific ligand for fgfr3 |
| 12/27/1996 | WO1996035715A3 Pcna binding substance |
| 12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
| 12/27/1996 | EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase |
| 12/27/1996 | EP0749982A1 Antioxidant grafted polysaccharides and their uses |
| 12/27/1996 | EP0749977A2 Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same |
| 12/27/1996 | EP0749967A1 Substituted benzothiazine derivative |
| 12/27/1996 | EP0749964A1 N-Heterocyclyl biphenyl sulfonamides |
| 12/27/1996 | EP0749753A2 Use of a powder or an extract of guava for treating allergic diseases |
| 12/27/1996 | EP0749752A1 Use of specific RXR receptor ligands |
| 12/27/1996 | EP0749751A2 Pharmaceutical composition for use in tteatment of diabetes |
| 12/27/1996 | EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof |
| 12/27/1996 | EP0749481A1 Humanized monoclonal antibodies against human interleukin-4 |
| 12/27/1996 | EP0749478A1 Yeast strains and modified albumins |
| 12/27/1996 | EP0749452A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
| 12/27/1996 | EP0749445A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment |
| 12/27/1996 | EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 12/27/1996 | EP0749424A1 Naphthalene derivatives as prostaglandin i2 agonists |
| 12/27/1996 | EP0749423A1 Piperidines and pyrrolidines |
| 12/27/1996 | EP0749422A1 Indole derivatives as cck receptor antagonists |
| 12/27/1996 | EP0749421A1 Sulphonamide derivatives as aspartyl protease inhibitors |
| 12/27/1996 | EP0749417A1 Cyano compounds and preparations thereof |
| 12/27/1996 | EP0749415A1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors |
| 12/27/1996 | EP0749318A1 Method of stimulating hematopoiesis with hemoglobin |
| 12/27/1996 | EP0749313A1 Method for treating 5ht 2b receptor related conditions |
| 12/27/1996 | EP0749309A1 Treatment of obsessive-compulsive disorders with 5-ht 2? antagonists |
| 12/27/1996 | EP0749308A1 Film coated tablet of paracetamol and domperidone |
| 12/27/1996 | EP0749306A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 12/27/1996 | EP0749302A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
| 12/27/1996 | EP0500853B1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 12/27/1996 | CA2223869A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/27/1996 | CA2223568A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 12/27/1996 | CA2222225A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system |
| 12/25/1996 | CN1138861A 2-heteroaryl-5,11-dihydro-6H-dipyrido|3,2-b:2',3'-3¨|1,4¨diazepines and their use in the prevention or treatment of HIV infection |
| 12/25/1996 | CN1138851A Metalloproteinase inhibitors |
| 12/25/1996 | CN1138588A Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 12/25/1996 | CN1138583A 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 12/25/1996 | CN1033646C 4,13-dioxy-bicyclo(8,2,1)tridecylenone derivative, its prepn. method and its intermediate product and said compound-contained medicament |
| 12/25/1996 | CN1033638C Novel alpha-mannosidase and fucosidase inhibitors |
| 12/24/1996 | US5587505 Triterpene derivatives and endothelin-receptor antagonists containing the same |
| 12/24/1996 | US5587479 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 12/24/1996 | US5587476 Fullerene derivatives, method of synthesizing them and their use |
| 12/24/1996 | US5587398 Affinity for serotonergic neurons; treating nervous system disorder; lipophilic |
| 12/24/1996 | US5587375 Azepinone compounds useful in the inhibition of ACE and NEP |
| 12/24/1996 | US5587371 Effective for treating hypoxic areas of solid neoplasms |